Prescription of Heroin for the Management of Heroin Dependence
- 1 May 2009
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 23 (6) , 463-476
Abstract
The prescription of heroin (diamorphine) for the management of heroin dependence is a controversial treatment approach that was limited to Britain until the 1990s. Since then a number of countries have embarked upon clinical trials of this approach, and it is currently licensed and available in several European countries. To date, six randomized controlled trials (RCTs) with over 1600 patients and several cohort studies have examined injected (or inhaled) heroin treatment. This article reviews relevant clinical pharmacology, how heroin treatment programmes are delivered, and the evidence regarding safety, efficacy and cost-effectiveness from RCTs. Heroin is usually prescribed in intravenous dosages of 300–500 mg/day, divided in two or three doses. Uncommon but serious side effects include seizures and respiratory depression immediately following injection. Despite methodological shortcomings, RCTs generally indicate that heroin treatment results in a comparable retention, improved general health and psychosocial functioning, and less self-reported illicit heroin use than oral methadone treatment. Cost-effectiveness studies indicate heroin treatment to be more expensive to deliver but to result in savings in the criminal justice sector. There has been debate regarding how heroin treatment should be positioned within the range of treatment approaches for this condition. There is increasing consensus that, in countries that have robust and accessible treatment systems for heroin users, heroin treatment is suited to a minority of heroin users as a second-line treatment for those individuals who do not respond to methadone or buprenorphine treatment delivered under optimal conditions.Keywords
This publication has 50 references indexed in Scilit:
- The Fine Line between Harm Reduction and Harm Production – Development of a Clinical Policy on Femoral (Groin) InjectingEuropean Addiction Research, 2008
- Pregnancy and Birth under Maintenance Treatment with Diamorphine (Heroin): A Case ReportEuropean Addiction Research, 2008
- Heroin-assisted Treatment (HAT) a Decade Later: A Brief Update on Science and PoliticsJournal of Urban Health, 2007
- The current status of heroin prescription treatment for heroin dependenceExpert Opinion on Drug Safety, 2005
- What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing?Drug and Alcohol Review, 2003
- Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from LondonAddiction, 2000
- Letter to the EditorAddiction, 2000
- Heroin prescribing in the “British System” of the mid 1990s: data from the 1995 national survey of community pharmacies in England and WalesDrug and Alcohol Review, 1997
- ‘Horse trading’: prescribing injectable opiates to opiate addicts. A descriptive studyDrug and Alcohol Review, 1992
- The Pharmacokinetics of Heroin in Patients with Chronic PainNew England Journal of Medicine, 1984